Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amantadine for behavioral and executive problems after frontal acquired brain injury
NL-OMON45205Active, not recruiting
- Sponsor
- GGZ Oost Brabant
- Start
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of amantadine in acquired brain injury (ABI) (2 arms), sponsored by GGZ Oost Brabant. Primary endpoints: Behavioral problems measured by Neuro Psychiatric Inventory, Individual target behavior measured by Visual Analogue Scale and 1 more. Started Oct 2015; status: active, not recruiting.
02
Drugs
amantadine
03
Conditions
acquired brain injury (ABI)
Beyond the preview
Go deeper on NL-OMON45205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45205.